• SENSEX 74,442.21
    -339.55 (--0.45%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Solar Industries
    19,273.75 11,641.10(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • TCS
    2,322.50 3,336.70(%)
  • Reliance Industries
    1,248.50 1,250.55(%)
  • Pine Labs
    191.50 134.75(%)
  • Hero Motocorp
    5,325.55 6,390.00(%)
  • Gland Pharma
    2,881.95 1,575.00(%)
  • Netweb Technol.
    4,654.00 2,820.80(%)
  • SBI
    978.00 816.25(%)
  • JSW Holdings
    10,990.00 10,500.05(%)
  • Bharat Electron
    387.65 380.35(%)
  • Cummins India
    4,930.00 3,802.55(%)
  • Coforge
    1,777.20 1,008.50(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Dishman Carbogen Amcis Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67697.0
  • ISIN : INE385W01011
167.25 0 (-0.14%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    163.57

  • Today’s High

    168.35

  • Open

    167.49

  • Perv Close

    167.49

  • 52W Low

    128.50

  • 52W High

    321.95

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2,622.20

  • Div & Yield %

    0.00

  • Book Value(₹)

    247.62

  • Debt-Equity Ratio

    -0.14

  • AGM Date

    11-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    2,622.20

  • RONW (%)

    -2.68

  • ROCE (%)

    -0.03

Score Board

  • Equity (₹ in Cr.)

    31.36

  • BV (₹)

    247.60

  • Sales( ₹ in Cr.)

    231.56

  • NP (in Cr.)

    -39.53

  • NP Var(%)

    -254.0

  • Div%

    0.0

  • CPS (₹)

    1.50

  • EPS (₹)

    -2.50

  • Traded Value (₹ in Lakhs)

    2,622.98

  • 52 Week High

    321.95

  • 52 Week Low

    128.50

  • Price BSE

    167.0

  • Price NSE

    167.00

  • Market Capital( in Cr.)

    2,622.98

  • P/C Ratio

    113.60

  • P/E Ratio

    -66.20

  • Price Vs.BV

    -2.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 231.56 399.84 327.35 402.55 306.61 200.32
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 231.56 399.84 327.35 402.55 306.61 200.32
Other Income 84.52 32.98 63.05 52.16 60.39 66.15
Stock Adjustments 16.36 -14.00 -8.27 -8.00 7.70 -22.54
Total Income 332.44 418.82 382.13 446.71 374.70 243.93
EXPENDITURE :            
Raw Materials 55.67 117.01 107.70 163.35 107.11 75.04
Power and Fuel Cost 23.87 32.16 28.71 33.07 24.83 12.78
Employee Cost 86.63 90.15 91.54 86.13 79.04 58.23
Other Manufacturing Expenses 20.96 21.69 27.94 31.21 22.57 18.95
Selling and Administration Expenses 52.50 50.59 46.30 52.54 46.03 28.90
Miscellaneous Expenses 2.97 2.45 13.14 22.49 2.21 43.20
Employee Benefit Expenses 86.63 90.15 91.54 86.13 79.04 58.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 242.60 314.05 315.33 388.79 281.79 237.10
Operating Profit 89.84 104.77 66.80 57.92 92.91 6.83
Interest 86.52 70.40 68.19 57.92 37.23 34.17
Gross Profit 3.32 34.37 -1.39 0.00 55.68 -27.34
Depreciation 62.57 65.20 101.61 96.20 140.07 141.35
Profit Before Tax -59.25 -30.83 -103.00 -96.20 -84.39 -168.69
Current Tax 0.00 0.00 11.06 0.00 0.00 17.97
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -20.85 -20.96 -37.65 -37.33 -52.84 46.15
Reported Net Profit -38.40 -9.87 -76.41 -58.87 -31.55 -232.81
Extraordinary Items 1.13 1.31 -1.02 -2.79 -0.79 2.52
Adjusted Net Profit -39.53 -11.18 -75.39 -56.08 -30.76 -235.33
Adjustment below Net Profit 0.00 0.49 -0.07 0.33 0.10 -0.51
P & L Balance brought forward -320.31 -310.93 -234.45 -175.91 -144.47 88.85
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -358.71 -320.31 -310.93 -234.45 -175.92 -144.47
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -2.45 -0.63 -4.87 -3.75 -2.01 -14.85
Earnings Per Share(Adj)-Unit Curr -2.45 -0.63 -4.87 -3.75 -2.01 -14.85
Book Value 247.59 257.05 258.46 262.39 269.88 298.13
Book Value(Adj)-Unit Curr 247.59 257.05 258.46 262.39 269.88 298.13

Shareholding Pattern

  • Promoter Group

    59.32%

  • Public Share Holding

    40.68%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 93,002,442 59.32 93,002,442 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,000 0.00 5,000 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 93,007,442 59.32 93,007,442 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 10,758,633 6.86 10,758,633 51
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,217,972 1.41 2,217,972 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,019,900 0.65 1,019,900 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,996,505 8.93 13,996,505 60
2] Non Institution
Bodies Corporate 2,392,068 1.53 2,392,068 245
Clearing Members 72,058 0.05 72,058 24
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,671,143 1.07 1,671,143 1,026
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,684,556 1.07 1,684,556 1,306
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 19,351,106 12.34 19,351,106 31
Individuals holding nominal share capital up to Rs. 1 lakh 23,480,176 14.98 23,479,491 46,694
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 9,734 0.01 9,734 3
Others 29,216 0.02 29,216 2
Sub Total 49,779,148 31.75 49,778,463 49,365
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 156,783,095 100.00 156,782,410 49,430

Company Background

Dishman Carbogen Amcis LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Dishman Carbogen Amcis Ltd
  • BSE Code : 67697.0
  • ISIN : INE385W01011

  • Incorporation Year

    2007

  • Registered Office

    Dishman Corporate House
    Iscon-Bopal Road Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    91-2717-400102/124

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Shrima Dave

  • Auditor

    T R Chadha & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Dishman Carbogen Amcis Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Dishman Carbogen 167.30 316.08 231.56 -40.41 0.00
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77